JP2018511555A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018511555A5 JP2018511555A5 JP2017538667A JP2017538667A JP2018511555A5 JP 2018511555 A5 JP2018511555 A5 JP 2018511555A5 JP 2017538667 A JP2017538667 A JP 2017538667A JP 2017538667 A JP2017538667 A JP 2017538667A JP 2018511555 A5 JP2018511555 A5 JP 2018511555A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- modified oligonucleotide
- wing segment
- composition according
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C*OC1C2(CO*)OC(*)C1***21CC1 Chemical compound C*OC1C2(CO*)OC(*)C1***21CC1 0.000 description 5
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562126439P | 2015-02-27 | 2015-02-27 | |
| US62/126,439 | 2015-02-27 | ||
| PCT/US2016/019728 WO2016138355A1 (en) | 2015-02-27 | 2016-02-26 | Modulation of apolipoprotein c-iii (apociii) expression in lipodystrophy populations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018511555A JP2018511555A (ja) | 2018-04-26 |
| JP2018511555A5 true JP2018511555A5 (enExample) | 2020-06-18 |
Family
ID=56789093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017538667A Pending JP2018511555A (ja) | 2015-02-27 | 2016-02-26 | リポジストロフィー集団におけるアポリポタンパク質Ｃ−ＩＩＩ（ＡｐｏＣＩＩＩ）発現の調節 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20180245076A1 (enExample) |
| EP (1) | EP3270931A4 (enExample) |
| JP (1) | JP2018511555A (enExample) |
| KR (1) | KR20170122769A (enExample) |
| CN (1) | CN107405358A (enExample) |
| AU (1) | AU2016222548A1 (enExample) |
| BR (1) | BR112017015307A2 (enExample) |
| CA (1) | CA2977971A1 (enExample) |
| HK (1) | HK1248522A1 (enExample) |
| IL (1) | IL253346A0 (enExample) |
| MX (1) | MX2017011009A (enExample) |
| RU (1) | RU2737719C2 (enExample) |
| WO (1) | WO2016138355A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3509624T3 (pl) | 2016-09-12 | 2024-03-25 | Amryt Pharmaceuticals Inc. | Sposób wykrywania przeciwciał neutralizujących przeciwko leptynie |
| WO2018102397A1 (en) | 2016-11-29 | 2018-06-07 | PureTech Health LLC | Exosomes for delivery of therapeutic agents |
| CN116348125A (zh) * | 2020-10-02 | 2023-06-27 | Ionis制药公司 | 降低apociii表达的方法 |
| EP4372085A4 (en) * | 2021-07-16 | 2026-01-21 | Suzhou Ribo Life Science Co Ltd | Nucleic acid, composition and conjugate, container, preparation process and use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7598227B2 (en) * | 2003-04-16 | 2009-10-06 | Isis Pharmaceuticals Inc. | Modulation of apolipoprotein C-III expression |
| CN103354757A (zh) * | 2011-01-31 | 2013-10-16 | 卡迪拉保健有限公司 | 脂肪代谢障碍的治疗 |
| KR101800333B1 (ko) * | 2011-04-27 | 2017-11-22 | 아이오니스 파마수티컬즈, 인코포레이티드 | 아포지방단백질 ｃｉｉｉ （ａｐｏｃｉｉｉ） 발현의 조정 |
| KR20200123263A (ko) * | 2013-02-14 | 2020-10-28 | 아이오니스 파마수티컬즈, 인코포레이티드 | 지질단백질 리파제 결핍 (lpld) 모집단에서 아포지질단백질 c-iii (apociii) 발현의 조절 |
| WO2014205449A2 (en) * | 2013-06-21 | 2014-12-24 | Isis Pharmaceuticals, Inc. | Compounds and methods for modulating apolipoprotein c-iii expression for improving a diabetic profile |
| WO2015021141A1 (en) * | 2013-08-06 | 2015-02-12 | Amarin Pharmaceuticals Ireland Limited | Methods of treating a cardiovascular disorder in a subject on apo-c3 modulating therapy |
-
2016
- 2016-02-26 EP EP16756424.4A patent/EP3270931A4/en not_active Withdrawn
- 2016-02-26 KR KR1020177025758A patent/KR20170122769A/ko not_active Ceased
- 2016-02-26 HK HK18107740.8A patent/HK1248522A1/zh unknown
- 2016-02-26 CA CA2977971A patent/CA2977971A1/en not_active Abandoned
- 2016-02-26 RU RU2017133142A patent/RU2737719C2/ru active
- 2016-02-26 WO PCT/US2016/019728 patent/WO2016138355A1/en not_active Ceased
- 2016-02-26 US US15/553,946 patent/US20180245076A1/en not_active Abandoned
- 2016-02-26 JP JP2017538667A patent/JP2018511555A/ja active Pending
- 2016-02-26 AU AU2016222548A patent/AU2016222548A1/en not_active Abandoned
- 2016-02-26 MX MX2017011009A patent/MX2017011009A/es unknown
- 2016-02-26 BR BR112017015307A patent/BR112017015307A2/pt not_active Application Discontinuation
- 2016-02-26 CN CN201680009110.1A patent/CN107405358A/zh active Pending
-
2017
- 2017-07-06 IL IL253346A patent/IL253346A0/en unknown
-
2019
- 2019-07-31 US US16/528,387 patent/US20200095581A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014516516A5 (enExample) | ||
| JP2020111594A5 (enExample) | ||
| JP2016513110A5 (enExample) | ||
| RU2015151200A (ru) | Композиции и способы модулирования экспрессии аполипопротеина (а) | |
| JP2014513954A5 (enExample) | ||
| JP2018511555A5 (enExample) | ||
| JP6203707B2 (ja) | アポリポタンパク質ｃｉｉｉ（ａｐｏｃｉｉｉ）発現の調節 | |
| JP2014511686A5 (enExample) | ||
| JP2017505116A5 (enExample) | ||
| JP2014530004A5 (enExample) | ||
| JP2012050438A5 (enExample) | ||
| CN104994884B (zh) | 对脂蛋白脂肪酶缺乏(lpld)群体中的载脂蛋白c-iii(apociii)表达的调节 | |
| JP2017513469A5 (enExample) | ||
| Singerman | Combination therapy using the small interfering RNA bevasiranib | |
| JP2016522817A5 (enExample) | ||
| RU2708672C1 (ru) | Конъюгаты цитарабина для лечения рака | |
| JP2012050439A5 (enExample) | ||
| JP2020511155A5 (enExample) | ||
| JP2016171800A5 (enExample) | ||
| IL264288B (en) | Methods and compositions for modulating apolipoprotein(a) expression | |
| JP2013538560A5 (enExample) | ||
| JP2013516489A5 (enExample) | ||
| EA029137B1 (ru) | Модулирование экспрессии вируса гепатита в (hbv) | |
| JP2013518603A5 (enExample) | ||
| JP2009508527A5 (enExample) |